CBDP (cannabidiphorol) has been shown to be similar in structure to the popular cannabinoid CBD but unlike CBD, CBDP possesses a longer side chain, a feature that is believed to serve a lot of beneficial purposes. In THCP, the cannabinoid discovered alongside CBDP, the longer side chain helps improve receptor bonding however this is not the case in CBDP. Studies currently show that CBDP doesn’t do much to improve the poor receptor binding ability of CBD although it should be noted that biological tests are still in their early stages so it’s still quite early to draw final conclusions.
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and…
This November gathering will bring psychedelic education into conversation with music, visual art, comedy, philosophy,…
Ten p.m. on a Glendale balcony, two floors above the theater that just screened the…
We analyzed seven different 2026 rankings to find the true top 10 cannabis strains in…
A land-rooted look at the growers reshaping cannabis through living soil, ecological intelligence and regenerative…